Last week’s July 3rd edition of the New York Times reports that past and present brokers from mutual fund giant JPMorgan Chase were encouraged to favor JPMorgan products in their financial advisement to customers, even when competitor products were better performing or better suited to a consumer’s budget. Moreover, JPMorgan marketing materials are said to have exaggerated the profits made from at least one major offering. For a further definition of misrepresentation and unsuitability, as well as an understanding of potentially defective products, visit the Investors section of our firm’s website.
JPMorgan’s marketing measures appear to have led to several profitable post-crisis years for the company. This success has come despite a volatile market that has shaken investor confidence in funds, and findings from fund researcher Morningstar that since 2009, 42% of JPMorgan funds have failed to meet the average performance of comparable products.
There has been concern from market analysts that consumers in many cases are being sold JPMorgan products based on theoretical returns over actual performance. Apparently, one balanced JPMorgan portfolio boasts professes a hypothetical return of 15.39% of fees after fees over three years, the reported return was 13.87%, lower not only than the advertised hypothetical, but also the standard of comparison JPMorgan depicts in marketing materials.